New drug UP-818-CC passes first safety check in healthy people
NCT ID NCT07355621
First seen Jan 25, 2026 · Last updated May 15, 2026 · Updated 15 times
Summary
This early-stage study tested a new drug called UP-818-CC in 73 healthy Chinese volunteers to see if it is safe and how the body processes it. Participants received either the drug or a placebo as a single dose or daily doses for a week. The main goal was to check for side effects and measure drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huashan Hospital Fudan University
Shanghai, China
Conditions
Explore the condition pages connected to this study.